This website uses cookies

Read our Privacy policy and Terms of use for more information.

Asiatiqa Weekly Outlook is produced for senior decision-makers navigating the China-EU-Asia commercial corridor. For questions or briefing requests, reach the Asiatiqa team directly.

Asia's October Reckoning: Trade Walls Rise as Pharma Bridges Multiply

BLUF

  • Brussels prepares its most aggressive trade toolkit against China yet, including a potential Section 301 style emergency tariff instrument, ahead of EU Trade Chief Sefcovic's make or break visit to Beijing on October 8th and 9th. 

  • European and US pharma giants poured over $15 billion into Chinese biotech licensing deals in a single week (Novartis $7.8B, Novo $2.6B, AstraZeneca $2B, Merck $2.1B), revealing that decoupling has clear limits where innovation pipelines are concerned.

  • Southeast Asia's semiconductor corridor accelerates: Infineon opened a $1.4 billion plant in Thailand, South Korea posted record $120.9 billion monthly exports driven by a 263% chip surge, and Malaysia's electronics sector signals further investment expansion.

The Quick Take

Europe's Trade Doctrine Is Being Rewritten in Real Time

There is a moment in every strategic contest when the rules of engagement change. For EU and China trade relations, that moment is now.

What happened this week in Brussels was  the quiet collapse of a consensus that had governed European trade policy toward China for nearly two decades. Germany, the great defender of engagement, the country whose industrial model was built on selling machine tools to Guangdong and luxury sedans to Shanghai, has crossed the Rubicon. The BDI, Germany's most powerful industrial lobby, published a paper arguing that the cost of inaction now exceeds the cost of Chinese retaliation. Even the VDA, the automotive lobby that single handedly blocked EV tariffs in 2024, has acknowledged that trade distortions require defensive instruments. When the people who have the most to lose from a trade war start calling for weapons, the strategic calculus has fundamentally shifted.

The proposed toolkit is remarkable in its ambition. A diversification instrument forcing companies to maintain multiple suppliers. A solidarity fund to cushion retaliation. And the centrepiece: an emergency tariff mechanism modelled on America's Section 301, giving the Commission power to restrict imports across entire sectors without the glacial pace of product by product investigations. One official, quoted in the Watching China in Europe newsletter, said the instrument would allow Europe to cut China off from the European market within 24 hours. That is a deterrence doctrine.

Beijing understands the stakes. China's Commerce Ministry responded within hours, warning that simultaneous dialogue and pressure would destroy mutual trust. The China Chamber of Commerce to the EU called the 301 style tool a weaponisation of trade policy. But the warning came wrapped in a contradiction: China's own trade surplus with the EU hit €360 billion in 2025, and Denis Redonnet, the Commission's chief trade enforcement officer, told the European Parliament this week that nearly a quarter of all EU imports are rising at a worrying rate, with China as the main driver. Twenty seven new trade defence cases have been opened in 2026 alone, more than double the historical annual average.

The real question is not whether Europe will act. It will. The question is whether Beijing can offer enough concessions during Sefcovic's visit to shape the terms. Voluntary export limits on plug in hybrids, managed quotas on steel and chemicals, perhaps some symbolic market access for European firms. The diplomatic choreography matters, but the structural forces are now stronger than any single negotiation. Europe is building a trade architecture designed for permanent competition, not temporary friction. That is the story of this week, and potentially of this decade of relationship between EU and China.

Headlines

EU Weighs Sweeping New Trade Powers Against China Before Make or Break October

The Story: The European Commission is preparing a package of new trade instruments for EU leaders, including a diversification mandate forcing firms in critical sectors to maintain at least three suppliers, a solidarity fund to compensate companies hit by retaliation, and a potential emergency tariff tool modelled on the US Section 301 mechanism. EU Trade Chief Maros Sefcovic travels to Beijing on 8 and 9 October. Germany's BDI and even the previously resistant VDA automotive lobby now support defensive measures. China's Commerce Ministry warned that simultaneous dialogue and pressure would undermine mutual trust.

Why it matters: Germany moving from blocker to enabler of protectionist tools changes the political arithmetic in Brussels entirely. The proposed instruments could reshape supply chains across automotive, chemicals, textiles and machinery. The October summit will determine whether Europe opts for managed competition or escalatory confrontation with its second largest trading partner.

Big Pharma's $15 Billion China Shopping Spree Defies Decoupling Rhetoric

The Story: In a single week, Novartis licensed an mRNA autoimmune therapy from Abogen for up to $7.8 billion. Novo acquired rights to Hengrui's oral GLP 1 weight loss pill for up to $2.6 billion. AstraZeneca invested $2 billion in Summit Therapeutics to co develop Akeso's cancer immunotherapy. Merck paid up to $2.13 billion for SciBrunch's pre clinical cancer drug. GSK struck a $750 million deal with Chimagen Biosciences.

Why it matters: While trade walls rise in manufacturing, pharma capital flows in the opposite direction. Chinese biotech has matured from a cost arbitrage play into a genuine innovation source. This creates a strategic paradox: the same governments tightening tech export controls are watching their national champions deepen dependency on Chinese drug pipelines.

Infineon's $1.4 Billion Thailand Plant Anchors Southeast Asia's Chip Corridor

The Story: German chipmaker Infineon inaugurated a $1.4 billion backend semiconductor facility in Samut Prakan, Thailand, focused on power modules, advanced assembly, packaging and testing for EVs, energy storage and data centres. The plant will employ up to 5,000 workers. Thailand has attracted $27.2 billion in semiconductor and electronics investment between 2023 and H1 2026. Separately, nearly three quarters of electronics firms in Malaysia plan to increase investment.

Why it matters: Infineon's investment includes technology transfer, university partnerships and R&D, signalling a move up the value chain. Thailand's new five year plan (2028–2032) explicitly targets AI and semiconductors, creating a policy framework that mirrors what made China attractive a decade ago.

Japanese Companies Exit China in Record Numbers

The Story: As of June 2026, only 10,118 Japanese companies maintained a presence in mainland China, the lowest since tracking began in 2010, a 22% fall from 2024 and a 30% drop from the 2012 peak. Teikoku Databank described the shift as moving from expansion to restructuring. The exodus is driven by slowing Chinese growth, US tariffs and a diplomatic freeze following PM Takaichi's remarks on Taiwan.

Why it matters: Japan's corporate retreat is the canary in the coal mine for broader foreign investment trends in China. Their departure validates the supply chain diversification thesis and creates openings in Vietnam, India and Thailand. Geopolitical risk premiums on China exposure are now being priced into corporate strategy, not just financial markets.

Graph

Reading the chart: Chinese overseas vehicle sales are projected to reach 12 million units in 2026, an eleven fold increase from 1.08 million in 2020. The acceleration is staggering: BYD posted an 85.7% year on year surge in the first eight months, while Chery's exports jumped 68.2%. This is the single data point that explains why Brussels is scrambling to build new trade defences. It also explains why Beijing issued guidelines in September requiring carmakers to avoid steep discounts abroad: the government itself recognises that unchecked export aggression risks triggering the very protectionism now materialising in Europe.

Quote

❝

Even if de-risking entails costs, including in the form of counter-reactions, passivity would in the long term be economically considerably more costly and irresponsible from a security policy perspective

Federation of German Industries (BDI), Policy Paper, September 2026

This is Germany's most influential industrial lobby group telling its own members, and the government, that the era of hedging is over. When the BDI says the cost of doing nothing exceeds the cost of retaliation, it gives political cover to every protectionist measure Brussels is preparing. The statement marks the end of Germany's role as China's advocate inside the EU.

The Risk Matrix

The Regulatory Horizon

What to Watch Next Week

  • EU Trade Chief Sefcovic in Beijing (8–9 October): The most consequential EU and China trade meeting of 2026. Watch for any signals on voluntary Chinese export limits on plug in hybrids and whether Beijing offers market access concessions. The outcome directly shapes the December trade package.

  • EU European Council Summit (mid October): Leaders will review the Sefcovic visit results and are expected to greenlight the Commission to draft new trade instruments. Watch for whether China is named in the summit conclusions, a diplomatic signal that would mark a significant escalation.

  • China's NPC Standing Committee 25th Session (late October): The revised National Defence Mobilisation Law took effect 01 October. The Standing Committee session may address economic legislation and could signal further stimulus measures following the mini stimulus package announced this week.

Sources

Title

Source

EU weighs sweeping new trade powers against China before make or break October

China driving worrying rise in EU imports, Commission official says

China Warns Broad EU Tariffs Could Disrupt Trade Negotiations

China vows response if EU introduces moves targeting Chinese trade

Novartis Inks Chinese mRNA Therapy Deal for Up to $7.8 Billion

Novo buys rights to Chinese weight loss pill in $2.6bn deal

AstraZeneca, Merck, Novo deals boost Chinese biotech as global interest grows

Infineon opens plant near Bangkok as Thailand boosts chip ambitions

Infineon opens US$1.4 billion Thailand plant as semiconductor investment moves up the value chain

South Korea's Monthly Exports Hit Record as Chip Boom Rolls on

Three fourths of electronics firms in Malaysia to lift investment: AmCham

Japanese companies exit China in record numbers

China's carmakers eye record 12 million overseas sales in 2026

EU steel exports hit by high energy costs, tariffs and China oversupply

VW, Gotion ramp up battery production in Europe, Morocco amid rising EV demand

Volkswagen benefited from €1.5bn in German EV subsidies as it lobbies EU to hit Chinese cars harder

CATL Starts Battery Production at Hungary Plant

China Posts $378 Billion Current Account Surplus Driven by Strong Exports, AI

China's Manufacturing Activity Returns to Expansion

China services growth hits three month high, private PMI shows

China unveils mortgage subsidies to boost economy

China launches mini stimulus targeting affordable homes, infrastructure

China ends tax break on lithium ion EV batteries after 11 years

China's Industrial Profit Growth Slows to 4.2% as Unpaid Bills Mount

China's generative AI user base crosses 700 million

China's R&D spending hits record 2.8% of GDP, beating OECD average

China accounted for 59% of global industrial robot installations in 2025

China's Nio and Geely deepen commitment to EV battery swapping tech

China's CXMT to favour domestic suppliers in $5.2B memory chip capacity push

India's factory growth climbs to 7 month high on surging demand

India's erratic monsoon plays havoc with harvests

Indian Stocks Are Breaking Long Held Supports as Selloff Deepens

Indonesia's 30% Stock Rout Lures Swedish Fund in First Ever Bet

Indonesia's central bank raises bond buying in September

Thailand is making AI and semiconductors the focus of its next five year development plan

Thailand Eyes Pivot to Short Term Debt as Bond Volatility Rises

Asian markets hold up despite bond rout as US yields enter a structurally higher regime

Nearly 200 foreign invested enterprises in Vietnam to pay global minimum tax

Vietnam property stocks slide back to 2022 lows

Philippine nickel exports to Indonesia soar after output quotas cut

China's gas turbine makers aim to challenge global giants. Is Malaysia the start?

Consumer spending picks up in Hong Kong, retail sales rising 5.6% in August

JAC Motors in talks with Huawei and Stellantis on Maserati collaboration

NPC Calendar: October 2026

SAFE Releases China's Balance of Payments for Q2 2026

Keep Reading